MicroRNA-Based Diagnostic Identifies Squamous Lung Cancer With 96 Percent Sensitivity, New York University Study
Medical News Today -- A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical Center, one of the authors of the study published on-line ahead of print in the Journal of Clinical Oncology.